A Duke Health research team has uncovered a collection of biomarkers that might help determine whether pancreatic cysts are likely to develop into cancer or stay benign.
LUND, Sweden, March 14, 2023 /PRNewswire/ Cantargia (Cantargia AB) (Nasdaq Stockholm: CANTA) today reported that two abstracts on its lead asset, the antibody nadunolimab (CAN04), have been
Smoking, gender, ethnicity, and even gum disease and blood type can be risk factors of pancreatic cancer, reveals new insights from [UCL Global Business.
FN Media Group Presents USA News Group News Commentary VANCOUVER, BC, March 14, 2023 /PRNewswire/ USA News Group - Optimism is on the rise as the American Cancer Society is reporting
Akamis Bio's clinical-stage NG-350A tumor gene therapy to be included as a novel combination therapeutic agent in a new cohort of the REVOLUTION platform study New cohort will assess the ability of
Cedars-Sinai Cancer Center researchers confirmed in a large-scale nationwide survey that pancreatic cancer rates are growing and rising faster among younger women, than males of the same age
HOUSTON, Jan. 25, 2023 /PRNewswire/ Data Bridge Market Research Published Latest Pancreatic Cancer Diagnostics Market Study by in-depth analysis of the current scenario, the Market size,